Patents by Inventor Finn Wiberg

Finn Wiberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for manufacturing recombinant polyclonal proteins
    Publication number: 20060275766
    Abstract: The invention relates to a method for manufacturing a recombinant polyclonal protein composition, in particular a recombinant polyclonal antibody composition. The method comprises obtaining a collection of cells transfected with a library of variant nucleic acid sequences, wherein each cell in the collection is transfected with and capable of expressing one member of the library, which encodes a distinct member of a polyclonal protein that binds a particular antigen and which is located at the same single site in the genome of individual cells in said collection, wherein said nucleic acid sequence is not naturally associated with said cell in the collection. The cells are cultured under suitable conditions for expression of the polyclonal protein, which is obtained from the cells or culture supernatant. The nucleic acid sequence id introduced into the cells by transfection with a library of vectors for site-specific integration.
    Type: Application
    Filed: January 7, 2004
    Publication date: December 7, 2006
    Inventors: John Haurum, Finn Wiberg, Vincent Coljee, Jacqueline Sharon, Chiou-Ying Yang
  • Method for the production of FVII
    Publication number: 20020160458
    Abstract: Disclosed is a method for high efficiency release of recombinant proteins in eukaryotic cells and more specifically, for enhancing the secretion of Factor VII by co-expression of kex2 endoprotease with FVII in cells of mammalian origin.
    Type: Application
    Filed: November 13, 2001
    Publication date: October 31, 2002
    Inventors: Helle Woldike, Finn Wiberg, Lars Soegaard Nielsen
  • Method for the production of factor VII
    Patent number: 6329176
    Abstract: Disclosed is a method for high efficiency release of recombinant proteins in eukaryotic cells and more specifically, for enhancing the secretion of Factor VII by co-expression of kex2 endoprotease with FVII in cells of mammalian origin.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: December 11, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Helle Wöldike, Finn Wiberg, Lars Søegaard Nielsen